Kiniksa Pharmaceuticals International (KNSA) Earnings Date & Reports

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

KNSA is expected to report earnings to rise 19.13% to 35 cents per share on November 03

Kiniksa Pharmaceuticals International KNSA Stock Earnings Reports

Q3'26

Est.

$0.36

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.06

Q4'25

Missed

by $0.18

Q3'25

Missed

by $0.09

The last earnings report on July 28 showed earnings per share of 30 cents, missing the estimate of 31 cents. With 212.45K shares outstanding, the current market capitalization sits at 5.99B.

View a ticker or compare two or three

KNSA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days